Rabita Singh

Rabita Singh

Director Director DIN 05316131
DIN 05316131 First appointment Oct 2012 Primary industry General Business
View timeline Unlock full profile Investments · shareholding · contact details
Current companies 0 active board seats
Past companies 1 historical roles
Total affiliations 1 Since Oct 2012
Shareholding value Locked Premium profile

About Rabita Singh

Rabita Singh has 13 years in corporate governance. Formerly with 1 company, such as Cellcyte Mediserve Private Limited. Engaged in General Business. Contributes to corporate operations.

DIN 05316131
Primary Designation Director
First Appointment 01 Oct 2012
Oldest Company Age Not Provided

Current companies

No current companies available.

Previous companies

Company Designation Appointment Founded Status
Cellcyte Mediserve Private Limited U24100DL2012PTC232261
Director 01 Oct 2012 2012 Active

Explore Director's current and past company associations Uncover their professional journey today!

Directorship timeline

Open interactive timeline →
Cellcyte Mediserve Private Limited
Premium access

Shareholding and investment profile for Rabita Singh

Company-level share counts, filed values, and quarterly changes require authenticated premium access.

  • Company-level holdings
  • Filed share counts
  • Reported values
  • Quarterly changes
Unlock shareholding

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Rabita Singh

Rabita Singh has 13 years in corporate governance. Formerly with 1 company, such as Cellcyte Mediserve Private Limited. Engaged in General Business. Contributes to corporate operations.

Rabita Singh is associated with 0 companies as a director.

Rabita Singh has expertise in General Business.

Rabita Singh has 13 years in corporate governance.

Explore millions of companies — effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals — all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available